Capstone Investment Advisors
VERA icon

Capstone Investment Advisors’s Vera Therapeutics VERA Stock Holding History

Capstone Investment Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,730
Closed -$231K – 1924
2026
Q1 		$231K Buy
+5,730
New +$247K ﹤0.01% 1478
2025
Q4 		– Sell
-11,983
Closed -$348K – 2077
2025
Q3 		$348K Buy
+11,983
New +$277K ﹤0.01% 1576
2024
Q2 		– Sell
-5,756
Closed -$248K – 2499
2024
Q1 		$248K Buy
+5,756
New +$205K ﹤0.01% 1915

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capstone Investment Advisors's VERA Position: Q2 2026 in Review

Capstone Investment Advisors sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 5,730 shares — an estimated $231K sold.

Capstone Investment Advisors first reported a position in VERA in Q1 2024 and held it in 3 quarters. The position peaked at $348K in Q3 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Capstone Investment Advisors reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 5,730 Vera Therapeutics shares in Q2 2026, an estimated $231K.
  • Capstone Investment Advisors first reported a position in Vera Therapeutics in Q1 2024 and held it in 3 quarters.
  • Capstone Investment Advisors's Vera Therapeutics position peaked at $348K in Q3 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.